Literature DB >> 15085195

MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs.

Giovanni Sitia1, Masanori Isogawa, Matteo Iannacone, Iain L Campbell, Francis V Chisari, Luca G Guidotti.   

Abstract

We recently showed that antigen-nonspecific inflammatory cells are recruited into the liver when hepatitis B virus (HBV)-specific CTLs are injected into HBV transgenic mice, and that this process amplifies the severity of liver disease. We also showed that the severity of CTL-induced liver disease is ameliorated by the depletion of Gr-1(+) cells (Gr-1 is an antigen highly expressed by neutrophils), which, secondarily, abolishes the intrahepatic recruitment of all antigen-nonspecific Gr-1(-) mononuclear cells (NK and NKT cells, T and B lymphocytes, monocytes, macrophages, dendritic cells) despite the strong induction of chemokine gene expression. Those results suggested that in addition to chemokine expression, CTL-induced functions are necessary for mononuclear cell recruitment to occur. We now report that MMPs known to be produced by Gr-1(+) cells are rapidly induced in the livers of CTL-injected mice. The inhibition of MMP activity reduced the intrahepatic recruitment of antigen-nonspecific mononuclear cells and much of the attending liver disease without affecting the migration or antiviral potential of antigen-specific CTLs. The notion that the inhibition of MMP activity is associated with maintenance of antiviral effects but diminished tissue damage may be significant for the development of immunotherapeutic approaches for the treatment of chronic HBV infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15085195      PMCID: PMC385409          DOI: 10.1172/JCI21087

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

Review 1.  The biology of chemokines and their receptors.

Authors:  D Rossi; A Zlotnik
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  RNAse protection assays for the simultaneous and semiquantitative analysis of multiple murine matrix metalloproteinase (MMP) and MMP inhibitor mRNAs.

Authors:  A Pagenstecher; A K Stalder; I L Campbell
Journal:  J Immunol Methods       Date:  1997-08-07       Impact factor: 2.303

Review 3.  Gelatinase B functions as regulator and effector in leukocyte biology.

Authors:  G Opdenakker; P E Van den Steen; B Dubois; I Nelissen; E Van Coillie; S Masure; P Proost; J Van Damme
Journal:  J Leukoc Biol       Date:  2001-06       Impact factor: 4.962

4.  Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes.

Authors:  L Y Oh; P H Larsen; C A Krekoski; D R Edwards; F Donovan; Z Werb; V W Yong
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

5.  Matrix metalloproteinases increase very early during experimental focal cerebral ischemia.

Authors:  J H Heo; J Lucero; T Abumiya; J A Koziol; B R Copeland; G J del Zoppo
Journal:  J Cereb Blood Flow Metab       Date:  1999-06       Impact factor: 6.200

6.  Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines.

Authors:  H McClary; R Koch; F V Chisari; L G Guidotti
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

7.  Regulation of liver inflammatory injury by signal transducer and activator of transcription-6.

Authors:  A Kato; H Yoshidome; M J Edwards; A B Lentsch
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

8.  Experimental metastasis is suppressed in MMP-9-deficient mice.

Authors:  T Itoh; M Tanioka; H Matsuda; H Nishimoto; T Yoshioka; R Suzuki; M Uehira
Journal:  Clin Exp Metastasis       Date:  1999-03       Impact factor: 5.150

9.  The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection.

Authors:  M K Maini; C Boni; C K Lee; J R Larrubia; S Reignat; G S Ogg; A S King; J Herberg; R Gilson; A Alisa; R Williams; D Vergani; N V Naoumov; C Ferrari; A Bertoletti
Journal:  J Exp Med       Date:  2000-04-17       Impact factor: 14.307

10.  CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells.

Authors:  H Nakano; M Yanagita; M D Gunn
Journal:  J Exp Med       Date:  2001-10-15       Impact factor: 14.307

View more
  46 in total

1.  Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV.

Authors:  Armanda Casrouge; Jérémie Decalf; Mina Ahloulay; Cyril Lababidi; Hala Mansour; Anaïs Vallet-Pichard; Vincent Mallet; Estelle Mottez; James Mapes; Arnaud Fontanet; Stanislas Pol; Matthew L Albert
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

2.  Antiviral treatment with alpha interferon up-regulates CD14 on liver macrophages and its soluble form in patients with chronic hepatitis B.

Authors:  Patrizia Carotenuto; Debby van Riel; André Artsen; Sven Bruijns; Fons G Uytdehaag; Jon D Laman; Andeltje B van Nunen; Pieter E Zondervan; Robert A De Man; Albert D Osterhaus; Oscar Pontesilli
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 3.  The paradox of matrix metalloproteinases in infectious disease.

Authors:  P T G Elkington; C M O'Kane; J S Friedland
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

4.  Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases.

Authors:  Alla L Zozulya; Emily Reinke; Dana C Baiu; Jozsef Karman; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

Review 5.  Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells.

Authors:  Barbara Rehermann
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

6.  Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection.

Authors:  Janine Kah; Sarene Koh; Tassilo Volz; Erica Ceccarello; Lena Allweiss; Marc Lütgehetmann; Antonio Bertoletti; Maura Dandri
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

7.  Transcriptomic analysis of the woodchuck model of chronic hepatitis B.

Authors:  Simon P Fletcher; Daniel J Chin; Yongmei Ji; A Leonardo Iniguez; Bruce Taillon; David C Swinney; Palanikumar Ravindran; Donavan T Cheng; Hans Bitter; Uri Lopatin; Han Ma; Klaus Klumpp; Stephan Menne
Journal:  Hepatology       Date:  2012-07-12       Impact factor: 17.425

8.  Platelets mediate cytotoxic T lymphocyte-induced liver damage.

Authors:  Matteo Iannacone; Giovanni Sitia; Masanori Isogawa; Patrizia Marchese; Maria G Castro; Pedro R Lowenstein; Francis V Chisari; Zaverio M Ruggeri; Luca G Guidotti
Journal:  Nat Med       Date:  2005-10-30       Impact factor: 53.440

9.  The L60V variation in hepatitis B virus core protein elicits new epitope-specific cytotoxic T lymphocytes and enhances viral replication.

Authors:  Yu Zhang; Yulin Ren; Yan Wu; Bao Zhao; Lipeng Qiu; Xiaodong Li; Dongping Xu; Jun Liu; George F Gao; Songdong Meng
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

Review 10.  Crosstalk between innate and adaptive immunity in hepatitis B virus infection.

Authors:  Li Wang; Kai Wang; Zhi-Qiang Zou
Journal:  World J Hepatol       Date:  2015-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.